Viyash Scientific · NSE: VIYASH · BSE: 512529
Q1 FY22 results · Apr–Jun 2021
Viyash Scientific reported revenue from operations of ₹320.51 crore (up 3.3% from Q1 FY21) and net profit of ₹2.65 crore (down 89.2% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a consolidated basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 320.51 | 310.26 | +3.3% | 361.82 | −11.4% |
| Other income | 2.67 | 1.55 | +72.6% | 1.37 | +94.7% |
| Total income | 323.18 | 311.81 | +3.6% | 363.20 | −11.0% |
| Profit before tax | 7.23 | 31.89 | −77.3% | 29.01 | −75.1% |
| Net profit for the period | 2.65 | 24.47 | −89.2% | 23.52 | −88.7% |
| Attributable to shareholders of the company | 0.87 | 20.92 | −95.8% | 20.63 | −95.8% |
| EPS, basic (₹) | 0.04 | 0.85 | −95.3% | 0.84 | −95.2% |
| Net margin (%) | 0.8 | 7.9 | 6.5 |
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 46.66 | 59.24 | −21.2% | 69.48 | −32.8% |
| Other income | 5.76 | 2.27 | +153.3% | 5.92 | −2.7% |
| Total income | 52.42 | 61.52 | −14.8% | 75.40 | −30.5% |
| Profit before tax | (0.87) | 8.80 | Turned loss | 6.03 | Turned loss |
| Net profit for the period | (0.61) | 6.91 | Turned loss | 4.64 | Turned loss |
| EPS, basic (₹) | (0.02) | 0.28 | Turned loss | 0.19 | Turned loss |
| Net margin (%) | -1.3 | 11.7 | 6.7 |
Consolidated
- Filed with BSE
- 11 Aug 2021, 17:18 IST
- Board meeting
- 10 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Aug 2021, 17:18 IST
- Board meeting
- 10 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE